Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.

Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoNo Change Detected
- Check18 days agoNo Change Detected
- Check25 days agoChange Detected- Added a prominent notice about potential outages due to lapse in government funding and updated operating status guidance. - Updated version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check33 days agoChange DetectedPage revision updated from v3.0.2 to v3.1.0, with new contact emails and phone numbers added.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated to v3.0.2. The old v3.0.1 revision and the Back to Top link were removed.SummaryDifference0.2%

- Check54 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%

- Check61 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of pembrolizumab, while several specific terms and resources related to cancer treatment have been removed.SummaryDifference3%

- Check76 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.